Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Revenue (2020 - 2023)

Pliant Therapeutics has reported Revenue over the past 4 years, most recently at $248000.0 for Q2 2023.

  • Quarterly Revenue fell 95.03% to $248000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $248000.0 through Mar 2024, down 97.46% year-over-year, with the annual reading at $1.6 million for FY2023, 83.69% down from the prior year.
  • Revenue was $248000.0 for Q2 2023 at Pliant Therapeutics, down from $1.3 million in the prior quarter.
  • Over five years, Revenue peaked at $28.9 million in Q1 2020 and troughed at $248000.0 in Q2 2023.
  • The 4-year median for Revenue is $2.0 million (2021), against an average of $4.3 million.
  • Year-over-year, Revenue surged 178.87% in 2022 and then crashed 95.03% in 2023.
  • A 4-year view of Revenue shows it stood at $4.5 million in 2020, then tumbled by 55.23% to $2.0 million in 2021, then dropped by 1.7% to $2.0 million in 2022, then plummeted by 87.38% to $248000.0 in 2023.
  • Per Business Quant, the three most recent readings for PLRX's Revenue are $248000.0 (Q2 2023), $1.3 million (Q1 2023), and $2.0 million (Q4 2022).